Evidence map›Paper›PMID 25253942›Full record

ReviewWorld journal of gastroenterology2014

Early-onset colorectal cancer: a sporadic or inherited disease?

Vittoria Stigliano, Lupe Sanchez-Mete, Aline Martayan, Marcello Anti

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Geographic and age-related variations in mutational processes in colorectal cancer.medRxiv : the preprint server for health sciences · 2025
    Article
  9. Mutational and co-mutational landscape of early onset colorectal cancer.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2025
    Article
  10. Review
  11. Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.Cellular and molecular gastroenterology and hepatology · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Young-onset colorectal cancer.Nature reviews. Disease primers · 2023
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vittoria StiglianoVittoria Stigliano, Lupe Sanchez-Mete, Marcello Anti, Division of Gastroenterology and Digestive Endoscopy, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Lupe Sanchez-MeteVittoria Stigliano, Lupe Sanchez-Mete, Marcello Anti, Division of Gastroenterology and Digestive Endoscopy, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Aline MartayanVittoria Stigliano, Lupe Sanchez-Mete, Marcello Anti, Division of Gastroenterology and Digestive Endoscopy, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Marcello AntiVittoria Stigliano, Lupe Sanchez-Mete, Marcello Anti, Division of Gastroenterology and Digestive Endoscopy, Regina Elena National Cancer Institute, 00144 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is the third most common cancer diagnosed worldwide. Although epidemiology data show a marked variability around the world, its overall incidence rate shows a slow but steady decrease, mainly in developed countries. Conversely, early-onset colorectal cancer appears to display an opposite trend with an overall prevalence in United States and European Union ranging from 3.0% and 8.6%. Colorectal cancer has a substantial proportion of familial cases. In particular, early age at onset is especially suggestive of hereditary predisposition. The clinicopathological and molecular features of colorectal cancer cases show a marked heterogeneity not only between early- and late-onset cases but also within the early-onset group. Two distinct subtypes of early-onset colorectal cancers can be identified: a "sporadic" subtype, usually without family history, and an inherited subtype arising in the context of well defined hereditary syndromes. The pathogenesis of the early-onset disease is substantially well characterized in the inherited subtype, which is mainly associated to the Lynch syndrome and occasionally to other rare mendelian diseases, whereas in the "sporadic" subtype the origin of the disease may be attributed to the presence of various common/rare genetic variants, so far largely unidentified, displaying variable penetrance. These variants are thought to act cumulatively to increase the risk of colorectal cancer, and presumably to also anticipate its onset. Efforts are ongoing in the attempt to unravel the intricate genetic basis of this "sporadic" early-onset disease. A better knowledge of molecular entities and pathways may impact on family-tailored prevention and clinical management strategies.

Indexed as

Genetic VariationAdultAge of OnsetColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisFemaleGenetic Predisposition to DiseaseHeredityHumansMaleMiddle AgedNeoplastic Syndromes, HereditaryPedigreePeutz-Jeghers SyndromePhenotypePrevalenceEarly-onset colorectal cancerEpidemiologyHereditary syndromeLynch syndromeMUTYH-associated polyposis

Identifiers

PMID25253942
PMCPMC4168075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.